Home

Biblio

Export 15 results:
Sort by: Author Keyword Title Type [ Year (Desc)]
Filters: Author is Ware, LB  [Clear All Filters]
2008
Calfee, CS, Ware LB, Eisner MD, Parsons PE, Thompson BT, Wickersham N, Matthay MA, the NHLBI ARDS Network.  2008.  Plasma Receptor for Advanced Glycation End-Products And Clinical Outcomes in Acute Lung Injury. Thorax, epub.
Calfee CS, Eisner MD, Parsons PE, Thompson BT, Conner ER J, Matthay MA, Ware LB, the NHLBI ARDS Network.  2008.  Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury. Intensive Care Med. epub.
2007
Calfee, CS, Eisner MD, Ware LB, Thompson BT, Parsons PE, Wheeler AP, Korpak A, Matthay MA, Network A R D S, National Heart Lung et al..  2007.  Trauma-associated lung injury differs clinically and biologically from acute lung injury due to other clinical disorders. Crit Care Med. 35(10):2243-50.
Ware, LB, Matthay MA, Parsons PE, Thompson BT, Januzzi JL, Eisner MD.  2007.  Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.. Crit Care Med. . 35(8):1821-8.
Rice, TW, Wheeler AP, Bernard GR, Hayden DL, Schoenfeld DA, Ware LB.  2007.  Comparison of the Sp02/FI02 Ration and the PaO 2/FI02 in Patients with Acute Lung Injury or ARDS. American College of Chest Physicians. (132):410-417.
McClintock, DE, Ware LB, Eisner MD, Wickersham N, Thompson BT, Matthay MA.  2007.  Higher urine nitric oxide is associated with improved outcomes in patients with acute lung injury. American Journal of Respiratory and Critical Care Medicine. (175):256-262.
2006
Rice, TW, Wheeler AP, Bernard GR, Ware LB, ARDSNet NIH NHLBI/.  2006.  Comparison of SpO2/FiO2 ratio to PaO2/FiO2 ratio in the diagnosis of ALI and ARDS. ATS. Abstract
2005
Parsons, PE, Matthay MA, Ware LB, Eisner MD.  2005.  Elevated Plasma Levels of Soluble TNF Receptors are Associated with Morbidity and Mortality in Patients with Acute Lung Injury. Am J Physiol Lung Cell Mol Physiol. 288:L426-431.
2004
Ware, LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA, ARDSNet NIH NHLBI/.  2004.  Significance of von Willebrand Factor in Septic and Non-Septic Patients with Acute Lung Injury. Am J Resp Crit Care Med. :ePub.
Ware, LB, Eisner MD, Wickersham N, Olman MA, Thompson BT, Parsons PE, Matthay MA, ARDSNet NIH NHLBI/.  2004.  Plasminogen activator inhibitor-1 (PAI-1), a marker of impaired fibrinolysis, is associated with higher mortality in patients wi. ATS. Abstract
2003
Eisner, MD, Parsons PE, Matthay MA, Ware LB, Greene K, ARDSNet NIH NHLBI/.  2003.  Plasma Surfactant Protein Levels and Clinical Outcomes in Patients with Acute Lung Injury. Thorax. 58:983-988.
Ware, LB, Ancukiewicz M, Parsons PE, Matthay MA, ARDSNet NIH NHLBI/.  2003.  Prognostic value of of plasma protein C levels in patients with acute lung injury. ATS. Abstract
Eisner, MD, Parsons PE, Matthay MA, Ware LB, Greene K, ARDSNet NIH NHLBI/.  2003.  Prognostic value of plasma surfactant protein D level for clinical outcomes in patients with acute lung injury. ATS. Abstract
2002
Ware, LB, Eisner MD, Thompson BT, Parsons PE, Matthay MA, ARDSNet NIH NHLBI/.  2002.  Von Willebrand Factor (VWF), a biochemical marker of endothelial injury, predicts outcome in ALI/ARDS and is not modulated by a . ATS 2002. Abstract
2001
Brower, RG, Ware LB, Berthiaume Y, Matthay MA.  2001.  Treatment of ARDS. Chest. 120(4):1347-1367.